Observe Medical ASASTU:OM50 -2.22%31 Days Payable is 623.89 as of Dec. 2025, which is 55% above its 10-year median of 401.69. GuruFocus rates STU:OM50 with a GF Score™ of 31/100 and a GF Value™ of €0.02. The stock has 5 warning signs investors should review. Among 793 Medical Devices & Instruments companies, Observe Medical ASA ranks better than 92.06% on this metric.
The historical rank and industry rank for Observe Medical ASA's Days Payable or its related term are showing as below:
STU:OM50'
s Days Payable Range Over the Past 10 Years
Min: 125.73 Med: 401.69 Max: 1438.8
Current: 490.01
During the past 10 years, Observe Medical ASA's highest Days Payable was 1438.80. The lowest was 125.73. And the median was 401.69.
STU:OM50's Days Payable is ranked better than 92.06% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs STU:OM50: 490.01
Observe Medical ASA's Days Payable
increased
from Dec. 2024 (472.75) to Dec. 2025 (623.89).
It may suggest that Observe Medical ASAdelayed paying its suppliers.
Observe Medical ASA Days Payable Related Terms
Observe Medical ASA Days Payable Historical Data
* Premium members only.
The historical data trend for Observe Medical ASA's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:OM50 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Observe Medical ASA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Observe Medical ASA Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Observe Medical ASA's Days Payable distribution charts can be found below:
* The bar in red indicates where Observe Medical ASA's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Observe Medical ASA's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Observe Medical ASA (STU:OM50) has a Days Payable of 623.89 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Observe Medical ASA and its competitors. This is 55% above median its historical median of 401.69. Over the past decade, Observe Medical ASA's Days Payable has ranged from 125.73 to 1,438.80. According to the industry distribution chart, Observe Medical ASA ranks #63 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 7.9%.
Is Observe Medical ASA's Days Payable too high?
Observe Medical ASA's current Days Payable of 623.89 is 55% above median its 10-year median of 401.69. Over the past 10 years, this metric has ranged from a low of 125.73 to a high of 1,438.80. The Medical Devices & Instruments industry median Days Payable is 67.87. Observe Medical ASA's value of 623.89 is 819.2% above this industry median. Based on the distribution chart, Observe Medical ASA ranks #63 out of 793 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Observe Medical ASA has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Observe Medical ASA's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Observe Medical ASA ranks #63 out of 793 companies for Days Payable. This places Observe Medical ASA in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Observe Medical ASA's value of 623.89 is 819.2% above this benchmark. Historically, Observe Medical ASA's own Days Payable has ranged from 125.73 to 1,438.80 over the past decade. While the company's 10-year median is 401.69 vs. the industry median of 67.87, Observe Medical ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Observe Medical ASA's current Days Payable of 623.89 is 819.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Observe Medical ASA and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Observe Medical ASA's current Days Payable is 623.89, which is 55% above median its own 10-year median of 401.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Observe Medical ASA stock overvalued right now?
Observe Medical ASA (STU:OM50) has a current Days Payable of 623.89. The stock's GF Value™ is €0.02, compared to a current price of €0.09 — trading 340% above its estimated fair value. The current Days Payable is 623.89, which is 55% above median its 10-year median of 401.69 and 819.2% above the Medical Devices & Instruments industry median of 67.87. Observe Medical ASA's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Observe Medical ASA (STU:OM50), the current Days Payable is 623.89 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Observe Medical ASA (STU:OM50) Overvalued in 2026?
Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued.
The current stock price of €0.09 is trading 340% above its estimated GF Value™ of €0.02.
Key valuation signals for STU:OM50:
Days Payable: 623.89 (55% above median its 10-year median of 401.69)
GF Value™: €0.02 vs. price of €0.09 (340% above fair value)
Industry Position: 819.2% above the Medical Devices & Instruments median (#63 of 793)
No single metric tells the full story. See the STU:OM50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
31GF Score
Get the complete analysis for STU:OM50
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OM50 has been successfully added to your 
